About Aortx
Aortx is a Healthcare company based in Redwood City (United States) founded in 2003, and was acquired by Hansen Medical in November 2007. Percutaneous aortic valve replacement devices are developed by AorTx. Aortx has raised $4.3 million across 3 funding rounds from investors including St. Jude Medical, Wilson Sonsini Goodrich & Rosati and Hansen Medical. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology; 3 of its 3 listed competitors have raised funding.
Company details
AorTx was founded in 2003 in Redwood City, United States, and operates in the medical device sector focused on cardiovascular therapies. Devices for percutaneous aortic valve replacement are provided, targeting high-risk patients as an alternative to open-heart surgery. Products are delivered via catheter-based systems, enabling valve implantation under local anesthesia in catheterization labs. The company was acquired by Hansen Medical in 2007 and serves the United States market.
- Headquarters Redwood City, United States
- Stage Acquired
- SectorsHealthcare
- Website aortx.com
- Acquired by Hansen Medical (Nov 2007)
- Total Equity Funding$4.3M (USD)
in 3 rounds
- Latest Funding Round$4.3M (USD), Series A
Dec 2006
- InvestorsSt. Jude Medical
& 5 more
- Acquired byHansen Medical
(Nov 2007)
Funding Insights of Aortx
Aortx has successfully raised a total of $4.3M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.3 million completed in December 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.3M
- Total Rounds 3
- Last Round Series A — $4.3M
- First Round $1.51M
(Apr 2005)
- Investors Count 5
All 3 funding rounds of Aortx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2006 | $4.3M | Series A | – | Saratoga Ventures, BioStar Capital | |
| Oct 2005 | $600,000 | Debt – Conventional | – | – | – |
| Apr 2005 | $1.51M | Debt – Conventional | – | – | – |
6 investors in total: 6 institutional.
Investors in Aortx
Aortx has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include St. Jude Medical, Wilson Sonsini Goodrich & Rosati and Hansen Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| saratogavc.com | ||||
| biostar.capital | ||||
Provider of legal services to technology and life science companies | 1961 | wsgr.com | Palo Alto, United States | |
Medical devices for cardiac and neuromodulation therapies are manufactured globally. | 1976 | sjm.com | Saint Paul, United States | |
Advanced robotics for catheter positioning in medical procedures are designed. | 2002 | hansenmedical.com | Mountain View, United States |
Investor details for Aortx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aortx
4 dated milestones of Aortx across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Aortx is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series A, of $4.3M.
- Exit Acquired by Hansen Medical.
Competitors of Aortx
Aortx has 3 listed competitors in our database, 3 of them funded. They include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| shockwavemedical.com | 2009 | Santa Clara, United States | $147.5M | 1,394 | Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed. | |
| cardiacdimensions.com | 2001 | Kirkland, United States | $260.8M | 31 | Invasive cardiac implants for heart failure treatment are developed. | |
| jenavalve.com | 2006 | Irvine, United States | $363.7M | 198 | Pericardial transcatheter aortic valve replacement systems are provided. |
Detailed competitors of Aortx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Aortx (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aortx
Aortx was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Aortx is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Aortx is a funded company, having raised a total of $4.3M across 3 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $1.51M, raised on Apr 2005.
AorTx was founded in 2003 in Redwood City, United States, and operates in the medical device sector focused on cardiovascular therapies. Devices for percutaneous aortic valve replacement are provided, targeting high-risk patients as an alternative to open-heart surgery. Products are delivered via catheter-based systems, enabling valve implantation under local anesthesia in catheterization labs. The company was acquired by Hansen Medical in 2007 and serves the United States market.
Aortx's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Aortx has 6 investors. Key investors include St. Jude Medical, Wilson Sonsini Goodrich & Rosati, Hansen Medical, Saratoga Ventures, and BioStar Capital.
Yes. Aortx was acquired by Hansen Medical in November 2007.